Jim Cramer has been recommending Level 3 Communications (LVLT) as early as March 2006 when the stock was at 4 dollars in change. He began to push the stock more heavily beginning in September 2006 when he featured it in the main segment of Mad Money saying it could be a double in the next 18 months. The stock was at approximately 4.5 so we will be looking for 9 dollars by March 2008. Since that call, we're currently sitting on an 11% return of which about 8% came from the first day after Cramer's initial recommendation. Between September and December of '06, Cramer announced that Level 3 Communications (LVLT) could or would double a total of four different times. On December 5, 2006, he changed his outlook to "will double within the next two years." On January 5, 2007, LVLT was placed highest among Savient Pharmaceuticals (SVNT) and Rite Aid Corporation (RAD) as the number one speculative stock of the year, citing the coming bandwidth shortage from rich media sites such as YouTube. He has no longer been claiming that the stock will double, but persistently refers to LVLT as one of his favorite speculative names.

Celgene (CELG) is one of the stocks with the most bullish mentions on Mad Money with Jim Cramer. It has been featured 13 times as a stock to buy in the special section. Cramer has called it a favorite of his and has predicted that it could be a possible takeover target a total of 3 times as lately as 4/30/2007. Bob Hugin, President and CEO of Celgene has been a guest on Mad Money's "On The Line" segment 3 seperate times, including once on Mad Money's Back to School Tour at University of Virginia's Darden Business School.

Jim Cramer has been negative on Elan Corporation (ELN) through 2005 and 2006 but when recently queried in the June 18, 2007 lightning round, he reported "I've been too negative on Elan (ELN)"..."At $21 bucks, it's got that great relationship with Biogen Idec (BIIB)"..."The safety of Tysabri is no longer in question as far as I'm concerned. That stock is going higher!" The stock has pulled back recently but Cramer has mentioned healthcare and drugs as industries that will benefit from the financials' downturn.